Immune-mediated regression of ‘metastatic’ neuroblastoma in the liver

This publication has 21 references indexed in Scilit:

• Establishment of animal liver metastatic model for C-1300 murine neuroblastoma and immunotherapy for it using OK-432, streptococcus preparation
  Journal of Surgical Research, 1992
• Heterogeneity of the lymphokine-activated killer cell phenotype
  Cellular Immunology, 1991
• Histological evidence of natural killer cell aggregation against malignant melanoma induced by adoptive immunotherapy with lymphokine-activated killer cells
  The Journal of Pathology, 1989
• The Influence of Natural Killer Cells in Neuroblastoma
  Archives of Surgery, 1989
• The Development of New Immunotherapies for the Treatment of Cancer Using Interleukin-2
  Annals of Surgery, 1988
• Immunotherapy of a murine tumor with interleukin 2. Increased sensitivity after MHC class I gene transfection.
  The Journal of Experimental Medicine, 1987
• Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced Cancer
  New England Journal of Medicine, 1987
• Administration of slowly released recombinant interleukin 2 Augmentation of the efficacy of adoptive immunotherapy with lymphokine-activated killer (LAK) cells
  Journal of Immunological Methods, 1986
• Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.
  Journal of Histochemistry & Cytochemistry, 1981
• Regression of Neuroblastoma IV-S: A Genetic Hypothesis
  New England Journal of Medicine, 1980